Stocktoria
Encompass Health Corp EHC
Encompass Health Corp financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9B | $5.4B | $4.8B | $4.3B | $4.0B | $3.6B | $4.6B | $4.3B | $3.9B | $3.6B |
| Operating income | — | — | — | $539.5M | $559.6M | $563.9M | $612.1M | $555.2M | $578.3M | $588.1M |
| Interest expense | — | — | $143.5M | $175.7M | $164.3M | $183.7M | $159.7M | $147.3M | $154.4M | $172.1M |
| Income tax | $192.9M | $150.2M | $132.2M | $100.1M | $101.9M | $74.7M | $115.9M | $118.9M | $145.8M | $163.9M |
| Net income | $566.2M | $455.7M | $352.0M | $271.0M | $412.2M | $284.2M | $358.7M | $292.3M | $271.1M | $247.6M |
| EPS (diluted) | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 | $2.85 | $3.61 | $2.93 | $2.84 | $2.59 |
| Operating cash flow | $1.2B | $1.0B | $850.8M | $705.8M | $715.8M | $704.7M | $635.3M | $762.4M | $658.3M | $640.2M |
| Free cash flow | — | — | — | $141.0M | $191.2M | $311.9M | $262.9M | $507.9M | $432.5M | $462.5M |
| Cash & equivalents | $72.2M | $85.4M | $69.1M | $21.8M | $49.4M | $185.6M | $60.0M | $69.2M | $54.4M | $40.5M |
| Total assets | $7.1B | $6.5B | $6.1B | $5.6B | $6.9B | $6.4B | $6.1B | $5.2B | $4.9B | $4.7B |
| Total liabilities | $3.8B | $3.7B | $3.8B | $3.8B | $4.5B | $4.4B | $4.1B | $3.4B | $3.2B | $3.6B |
| Shareholders' equity | $3.2B | $2.8B | $2.3B | $1.8B | $2.4B | $2.0B | $1.7B | $1.6B | $1.4B | $910.6M |
Growth · year-over-year · Revenue CAGR 5.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +10.5% | +11.9% | +10.4% | +8.3% | +12.6% | -22.6% | +7.7% | +9.3% | +7.4% | — |
| Net income growth | +24.2% | +29.5% | +29.9% | -34.3% | +45.0% | -20.8% | +22.7% | +7.8% | +9.5% | +35.2% |
| EPS growth | +24.2% | +28.5% | +28.5% | -34.3% | +44.2% | -21.1% | +23.2% | +3.2% | +9.7% | +35.6% |
| Free cash flow growth | — | — | — | -26.3% | -38.7% | +18.6% | -48.2% | +17.4% | -6.5% | +23.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.